Početna stranicaMEHCQ • OTCMKTS
add
Chrome Holding Co
3,20 $
Poslije radnog vremena:(1,25 %)−0,040
3,16 $
Zatvoreno: 17. lis, 16:02:12 GMT -4 · USD · OTCMKTS · Odricanje od odgovornosti
Preth. zaklj. cijena
3,16 $
Dnevni raspon
3,13 $ - 3,20 $
Godišnji raspon
0,47 $ - 6,21 $
Tržišna kapitalizacija
88,13 mil. USD
Prosječna količina
50,03 tis.
P/E omjer
-
Prinos dividende
-
Glavno tržište vrijednosnica
OTCMKTS
Vijesti s tržišta
Financijski podaci
Račun dobiti i gubitka
Prihod
Neto dohodak
(USD) | lip 2025.info | Godišnja promjena |
---|---|---|
Prihod | 25,42 mil. | −37,10 % |
Operativni troškovi | 44,24 mil. | −43,21 % |
Neto dohodak | −23,83 mil. | 65,67 % |
Neto profitabilnost | −93,74 | 45,41 % |
Zarada po dionici | — | — |
EBITDA | −28,49 mil. | 46,78 % |
Efektivna porezna stopa | — | — |
Bilanca stanja
Ukupna imovina
Ukupne obveze
(USD) | lip 2025.info | Godišnja promjena |
---|---|---|
Gotovinska i kratkoročna ulaganja | 39,83 mil. | −76,57 % |
Ukupna imovina | 144,33 mil. | −60,79 % |
Ukupne obveze | 187,19 mil. | −16,64 % |
Ukupni kapital | −42,86 mil. | — |
Dionice u optjecaju | 27,54 mil. | — |
Cijena prema knjigovodstvenoj vrijednosti | −2,03 | — |
Povrat imovine | −50,47 % | — |
Povrat kapitala | 438,85 % | — |
Tok novca
Neto promjena novca
(USD) | lip 2025.info | Godišnja promjena |
---|---|---|
Neto dohodak | −23,83 mil. | 65,67 % |
Gotovina od poslovanja | −28,99 mil. | 33,00 % |
Gotovina iz ulaganja | −1,03 mil. | 10,64 % |
Gotovina iz financiranja | 24,28 mil. | 269.711,11 % |
Neto promjena novca | −5,74 mil. | 87,07 % |
Slobodan tok novca | 22,86 mil. | 281,90 % |
Više
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California. It is best known for providing a direct-to-consumer genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism genotyping, to generate reports relating to the customer's ancestry and genetic predispositions to health-related topics. The company's name is derived from the 23 pairs of chromosomes in a diploid human cell.
Founded in 2006, 23andMe soon became the first company to begin offering autosomal DNA testing for ancestry, which all other major companies now use. Its saliva-based direct-to-consumer genetic testing business was named "Invention of the Year" by Time in 2008.
The company had a previously confrontational relationship with the United States Food and Drug Administration due to its genetic health tests; as of October 2015, DNA tests ordered in the US include a revised health component, per FDA approval. 23andMe has been selling a product with both ancestry and health-related components in Canada since October 2014, and in the UK since December 2014. Wikipedia
Osnovano
tra 2006
Web-lokacija
Zaposlenici
261